by University of New South Wales Research led by Dr. Katya Numbers from UNSW’s Centre for Healthy Brain Ageing (CHeBA) has shown that certain presentations of memory concerns by older adults are predictive of future dementia. The findings published today in PLOS ONEhighlight the importance of general practitioners in listening to their older adult patient...
Specially designed footwear reduces pain of knee osteoarthritis
by Boston University School of Medicine Wearing shoes specifically designed with a novel sole (biomechanical footwear) significantly reduces the pain associated with knee osteoarthritis. Knee osteoarthritis affects approximately 275 million people worldwide and in 2017 was estimated to account for 8.3 million years lived with disability. Acetaminophen, non-steroidal anti-inflammatory drugs and opioids are most commonly...
Transcranial direct current stimulation is a safe treatment
by University of Eastern Finland Transcranial direct current stimulation, tDCS, is a promising treatment for conditions such as depression and addictive disorders. New evidence on the safety of transcranial direct current stimulation was recently offered by a new study showing that tDCS does not affect metabolism. Transcranial direct current stimulation is a non-invasive method for...
Bone health declining in U.S. adults with and without prediabetes
(HealthDay)—The bone health of adults older than 40 years of age is declining for individuals both with normal glucose regulation and prediabetes, according to a study recently published in Diabetes Care. Chi Chen, M.D., from the Shanghai Jiao Tong University School of Medicine, and colleagues used data from the U.S. National Health and Nutrition Examination...
Buprenorphine-naloxone effectively treats narcotic bowel syndrome in a long-suffering patient
by American College of Physicians The combination of buprenorphine and naloxone should be investigated as a potential treatment for narcotic bowel syndrome. The drugs seem to work together to address the underlying pathology of the syndrome. Findings from a brief research report are published in Annals of Internal Medicine. Narcotic bowel syndrome is a chronic...
Century-old drug repurposed to fight diabetic foot ulcers
by Marcene Robinson, University at Buffalo Suramin, a 100-year old drug used to treat sleeping sickness, has been repurposed to fight oral mucositis and diabetic foot ulcers, according to University at Buffalo-supported research. The breakthrough, led by researchers at the University of Arizona with the support of Keith Kirkwood, DDS, Ph.D., Centennial Endowed Chair and...
Telehealth tools developed for Ebola improve COVID-19 care
by University of Virginia Telemedicine tools developed at UVA Health to battle Ebola have huge potential in the fight against COVID-19, UVA experts report in a new scientific paper. The tools, they say, allow doctors to provide personal, high-quality care while conserving vital personal protective equipment and reducing infection risks. The battle against highly contagious...
Insulins available at US pharmacies are consistent with product labeling
by JDRF JDRF, the American Diabetes Association (ADA), and The Leona M. and Harry B. Helmsley Charitable Trust, announce the results of a study examining the consistency and potency of insulin purchased at U.S. retail pharmacies. The study, led by University of Florida researcher Timothy Garrett and published in Diabetes Care, found all human and...
Scientists create first roadmap of human skeletal muscle development
by University of California, Los Angeles An interdisciplinary team of researchers at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at UCLA has developed a first-of-its-kind roadmap of how human skeletal muscle develops, including the formation of muscle stem cells. The study, published in the peer-reviewed journal Cell Stem Cell,...
ACR releases gout management guideline
by American College of Rheumatology Today, the American College of Rheumatology (ACR) released the 2020 Guideline for the Management of Gout. The updated guideline reflects new clinical evidence that became available since the ACR last released a treatment guideline for the condition in 2012, Among the 42 recommendations offered, addressing standard treat-to-target urate lowering therapy...